Rankings
▼
Calendar
MESO Q4 2019 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+15.7% YoY
Gross Profit
-$60M
-3065.4% margin
Operating Income
-$18M
-891.9% margin
Net Income
-$21M
-1053.7% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
+57.5%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$652M
Total Liabilities
$171M
Stockholders' Equity
$481M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+15.7%
Gross Profit
-$60M
-$421,000
-14222.1%
Operating Income
-$18M
-$23M
+23.1%
Net Income
-$21M
-$21M
+0.5%
← FY 2019
All Quarters
Q1 2020 →